Product Information
Phase Detail
Biosep SEC-s2000
BioSep SEC-s2000 SEC/ GFC phase is well suited for biogeneric aggregate, peptide therapeutics, PEGylated peptides, PEGylated small proteins
Biosep SEC-s2000
Biosep SEC-s2000
BioSep SEC-s2000 SEC/GFC phase has an exclusion range of:
- 1,000 - 300,000 Da (Native)
- 200 - 75,000 Da (0.5% SDS)
- 500 - 100,000 Da (6M GnHCl)
Particle Size 5 |
Recommended Use Ideal for biogeneric aggregate applications, peptide therapeutics, small proteins, PEGylated peptides, and PEGylated small proteins. |
Biosep SEC-s2000 Documents
Biosep SEC-s2000 Documents
Showing 1-4 of 4 results
| Type | Document Title |
|---|---|
| Brochures | BioSep GFC/SEC Brochure |
| Brochures | United States Pharmacopeia (USP) Allowable Adjustments Guide |
| Technical Notes | PEGylated Proteins by GFC (TN-1048) |
| Technical Notes | PEGylated Proteins by Reversed Phase HPLC (TN-1046) |
Phenomenex is a technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers worldwide.
CONNECT WITH US
